Concentrations of cefpirome in cerebrospinal fluid of children with bacterial meningitis after a single intravenous dose

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 1, 1998, Pages 199-201

  Friedland, Ian R ^a,c   Sultan, Eric ^b   Lehr, Karl H ^b   Lenfant, Bernard ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b SANOFI   (France)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFPIROME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; DEACETYLCEFOTAXIME; DEXAMETHASONE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BACTERIUM ISOLATION; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DRUG CEREBROSPINAL FLUID LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEIZURE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0031983691     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.1.199     Document Type: Article

References (16)

1. Bajaksouzian, S., M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum. 1996. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods. Antimicrob. Agents Chemother. 40:1973-1976.
2. Barry, A. L., S. D. Brown, and W. J. Novick. 1995. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates. Antimicrob. Agents Chemother. 39:2193-2196.
3. Bradley J. S., S. L. Kaplan, K. P. Klugman, and R. J. Leggiadro. 1995. Consensus: management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr. Infect. Dis. J. 14:1037-1041.
4. Cheng, A. F., T. K. Ling, A. W. Lam, K. S. Fung, and R. Wise. 1993. The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin, in comparison with other agents. J. Antimicrob. Chemother. 31:699-709.
5. Cherubin, C. E., R. H. K. Eng, R. Norrby, J. Modai, G. Humbert, and G. Overturf. 1989. Penetration of newer cephalosporins into cerebrospinal fluid Rev. Infect. Dis. 11:526-548.
6. Craig, W. A. 1993. The pharmacokinetics of cefpirome: rationale for a twelve-hour dosing regimen. Scand. J. Infect. Dis. 91(Suppl.):33-40.
7. Jehl, F., P. Birckel, and H. Monteil. 1987. Hospital routine analysis of penicillins, third generation cephalosporins and aztreonam by conventional and high-speed high-performance liquid chromatography. J. Chromatogr. 413:109-119.
8. Klugman, K. P., I. R. Friedland, and J. S. Bradley. 1995. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob. Agents Chemother. 39:1988-1992.
9. Lehr, K. H., and D. Weil. 1993. Determination of HR 810 in serum and plasma by HPLC. Report Hoechst AG 012145. Hoechst, Romainville, France.
10. Lutsar, I., A. Ahmed, I. R. Friedland, M. Trujillo, L. Wubbel, K. Olsen, and G. H. McCracken, Jr. 1997. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 41:2414-2417.
11. Paris, M. M., S. M. Hickey, M. I. Usher, S. Shelton, K. D. Olsen, and G. H. McCracken, Jr. 1994. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 38:1320-1324.
12. Reeves, D. S., M. J. Bywater, and H. A. Holt. 1993. The activity of cefpirome and ten other antibacterial agents against 2858 clinical isolates collected from 20 centres. J. Antimicrob. Chemother. 31:345-362.
13. Sanders, C. C. 1996. In vitro activity of fourth-generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamases. J. Chemother. 8:57-62.
14. Spangler, S. K., M. R., Jacobs, and P. C. Appelbaun. 1994. Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin. Antimicrob. Agents Chemother. 38:898-900.
15. Wolff, M., P. Chavanet, A. Kazmierczak, A. Pechinot, C. Demtons, H. Portier, and B. Lenfant. 1992. Diffusion of cefpirome into the cerebrospinal fluid of patients with purulent meningitis. J. Antimicrob. Chemother. 29 (Suppl. A):59-62.
16. Yost, R. L., and H. Derendorf. 1985. Rapid chromatographic determination of cefotaxime and its metabolite in biological fluid. J. Chromatogr. 341:131-138.